Literature DB >> 30457484

Virtual Hepatic Venous Pressure Gradient with CT Angiography (CHESS 1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension.

Xiaolong Qi1, Weimin An1, Fuquan Liu1, Ruizhao Qi1, Lei Wang1, Yanna Liu1, Chuan Liu1, Yi Xiang1, Jialiang Hui1, Zhao Liu1, Xingshun Qi1, Changchun Liu1, Baogang Peng1, Huiguo Ding1, Yongping Yang1, Xiaoshun He1, Jinlin Hou1, Jie Tian1, Zhiwei Li1.   

Abstract

Purpose To develop and validate a computational model for estimating hepatic venous pressure gradient (HVPG) based on CT angiographic images, termed virtual HVPG, to enable the noninvasive diagnosis of portal hypertension in patients with cirrhosis. Materials and Methods In this prospective multicenter diagnostic trial (ClinicalTrials.gov identifier: NCT02842697), 102 consecutive eligible participants (mean age, 47 years [range, 21-75 years]; 68 men with a mean age of 44 years [range, 21-73 years] and 34 women with a mean age of 52 years [range, 24-75 years]) were recruited from three high-volume liver centers between August 2016 and April 2017. All participants with cirrhosis of various causes underwent transjugular HVPG measurement, Doppler US, and CT angiography. Virtual HVPG was developed with a three-dimensional reconstructed model and computational fluid dynamics. Results In the training cohort (n = 29), the area under the receiver operating characteristic curve (AUC) of virtual HVPG in the prediction of clinically significant portal hypertension (CSPH) was 0.83 (95% confidence interval [CI]: 0.58, 1.00). The diagnostic performance was prospectively confirmed in the validation cohort (n = 73), with an AUC of 0.89 (95% CI: 0.81, 0.96). Inter- and intraobserver agreement was 0.88 and 0.96, respectively, suggesting the good reproducibility of virtual HVPG measurements. There was good correlation between virtual HVPG and invasive HVPG (R = 0.61, P < .001), with a satisfactory performance to rule out (7.3 mm Hg) and rule in (13.0 mm Hg) CSPH. Conclusion The accuracy of a computational model of virtual hepatic venous pressure gradient (HVPG) shows significant correlation with invasive HVPG. The virtual HVPG also showed a good performance in the noninvasive diagnosis of clinically significant portal hypertension in cirrhosis. © RSNA, 2018 Online supplemental material is available for this article. See also the editorial by Malayeri in this issue.

Entities:  

Mesh:

Year:  2018        PMID: 30457484     DOI: 10.1148/radiol.2018180425

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

Review 1.  Portal pressure monitoring-state-of-the-art and future perspective.

Authors:  Gang Xu; Fei Li; Yilei Mao
Journal:  Ann Transl Med       Date:  2019-10

Review 2.  Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver disease.

Authors:  Jérémy Dana; Aïna Venkatasamy; Antonio Saviano; Joachim Lupberger; Yujin Hoshida; Valérie Vilgrain; Pierre Nahon; Caroline Reinhold; Benoit Gallix; Thomas F Baumert
Journal:  Hepatol Int       Date:  2022-02-09       Impact factor: 9.029

Review 3.  Artificial intelligence in the diagnosis of cirrhosis and portal hypertension.

Authors:  Xiaoguo Li; Ning Kang; Xiaolong Qi; Yifei Huang
Journal:  J Med Ultrason (2001)       Date:  2021-11-17       Impact factor: 1.878

4.  The Presence of Ascites Affects the Predictive Value of HVPG on Early Rebleeding in Patients with Cirrhosis.

Authors:  Chuan Liu; Ruoyang Shao; Sining Wang; Guangchuan Wang; Lifen Wang; Mingyan Zhang; Yanna Liu; Mingkai Liang; Xiaoguo Li; Ning Kang; Jitao Wang; Dan Xu; Hua Mao; Chunqing Zhang; Xiaolong Qi
Journal:  Gastroenterol Res Pract       Date:  2020-11-24       Impact factor: 2.260

5.  Functional magnetic resonance imaging-based assessment of terlipressin vs. octreotide on renal function in cirrhotic patients with acute variceal bleeding (CHESS1903): study protocol of a multicenter randomized controlled trial.

Authors:  Xinwen Yan; Ruoyang Shao; Yuancheng Wang; Xiaorong Mao; Junqiang Lei; Liting Zhang; Jianjun Zheng; Aimin Liu; Huimin Zhao; Fengxiao Gao; Jitao Wang; Ping Li; Shengjuan Yao; Ming Xu; Jian Xu; Dengxiang Liu; Yuqiang Mi; Xijun Gong; Jun Ye; Mingming Deng; Tong Dang; Jiansong Ji; Chuxiao Shao; Chao Liu; Ye Gu; Yunhong Wu; Fengmei Wang; Gaojun Teng; Xun Li; Xingshun Qi; Shenghong Ju; Xiaolong Qi
Journal:  Ann Transl Med       Date:  2019-10

6.  Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases.

Authors:  Chihua Fang; Jihyun An; Antonio Bruno; Xiujun Cai; Jia Fan; Jiro Fujimoto; Rita Golfieri; Xishan Hao; Hongchi Jiang; Long R Jiao; Anand V Kulkarni; Hauke Lang; Cosmas Rinaldi A Lesmana; Qiang Li; Lianxin Liu; Yingbin Liu; Wanyee Lau; Qiping Lu; Kwan Man; Hitoshi Maruyama; Cristina Mosconi; Necati Örmeci; Michael Pavlides; Guilherme Rezende; Joo Hyun Sohn; Sombat Treeprasertsuk; Valérie Vilgrain; Hao Wen; Sai Wen; Xianyao Quan; Rafael Ximenes; Yinmo Yang; Bixiang Zhang; Weiqi Zhang; Peng Zhang; Shaoxiang Zhang; Xiaolong Qi
Journal:  Hepatol Int       Date:  2020-07-07       Impact factor: 6.047

7.  An imaging-based artificial intelligence model for non-invasive grading of hepatic venous pressure gradient in cirrhotic portal hypertension.

Authors:  Qian Yu; Yifei Huang; Xiaoguo Li; Michael Pavlides; Dengxiang Liu; Hongwu Luo; Huiguo Ding; Weimin An; Fuquan Liu; Changzeng Zuo; Chunqiang Lu; Tianyu Tang; Yuancheng Wang; Shan Huang; Chuan Liu; Tianlei Zheng; Ning Kang; Changchun Liu; Jitao Wang; Seray Akçalar; Emrecan Çelebioğlu; Evren Üstüner; Sadık Bilgiç; Qu Fang; Chi-Cheng Fu; Ruiping Zhang; Chengyan Wang; Jingwei Wei; Jie Tian; Necati Örmeci; Zeynep Ellik; Özgün Ömer Asiller; Shenghong Ju; Xiaolong Qi
Journal:  Cell Rep Med       Date:  2022-03-15

8.  Computed Tomography-Based Texture Features for the Risk Stratification of Portal Hypertension and Prediction of Survival in Patients With Cirrhosis: A Preliminary Study.

Authors:  Shang Wan; Yi Wei; Xin Zhang; Caiwei Yang; Fubi Hu; Bin Song
Journal:  Front Med (Lausanne)       Date:  2022-04-01

Review 9.  The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis.

Authors:  Thomas Reiberger
Journal:  Hepatol Commun       Date:  2021-12-14

10.  Development and validation of a nomogram for predicting varices needing treatment in compensated advanced chronic liver disease: A multicenter study.

Authors:  Jitao Wang; Wenxin Wei; Zhihui Duan; Jinlong Li; Yanna Liu; Chuan Liu; Liting Zhang; Qingge Zhang; Shengyun Zhou; Kunpeng Zhang; Fengxiao Gao; Xiaojuan Wang; Yong Liao; Dan Xu; Yifei Huang; Shuai Wang; Weiling Hu; Hua Mao; Ming Xu; Tong Dang; Bin Wu; Li Yang; Dengxiang Liu; Xiaolong Qi
Journal:  Saudi J Gastroenterol       Date:  2021 Nov-Dec       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.